Filing Details
- Accession Number:
- 0001144204-10-019877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-13 13:00:00
- Reporting Period:
- 2010-04-05
- Filing Date:
- 2010-04-13
- Accepted Time:
- 2010-04-13 17:11:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1038977 | S Michael Weiss | 787 7Th Avenue 48Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-04-05 | 290,100 | $3.58 | 1,768,167 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-04-05 | 200,000 | $1.30 | 1,968,167 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-12 | 150,000 | $4.12 | 1,818,167 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-04-12 | 150,000 | $1.30 | 1,968,167 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-13 | 20,100 | $4.80 | 1,948,067 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |